Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and eticlopride

3,4-dihydroxyphenylacetic acid has been researched along with eticlopride in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marshall, JF; O'Dell, SJ; Weihmuller, FB1
Bardo, MT; Brown, RW; Dwoskin, LP; Green, TA; Phillips, SB1
Izzo, E; Koob, GF; Sanna, PP1
Bishop, C; Taylor, JL; Walker, PD1

Other Studies

4 other study(ies) available for 3,4-dihydroxyphenylacetic acid and eticlopride

ArticleYear
Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists.
    Journal of neurochemistry, 1993, Volume: 60, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Corpus Striatum; Dialysis; Dopamine; Dopamine D2 Receptor Antagonists; Male; Methamphetamine; Nerve Endings; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides

1993
Locomotor stimulant effects of nornicotine: role of dopamine.
    Pharmacology, biochemistry, and behavior, 2002, Volume: 74, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Dihydroxyphenylalanine; Dopamine; Dopamine Antagonists; Drug Synergism; Male; Motor Activity; Nicotine; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley; Salicylamides; Stimulation, Chemical; Sympathectomy, Chemical; Sympatholytics

2002
Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Pharmacology, biochemistry, and behavior, 2005, Volume: 81, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Catalepsy; Corpus Striatum; Corticotropin-Releasing Hormone; Dextroamphetamine; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Injections, Intraventricular; Male; Mice; Motor Activity; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Dopamine D2; Salicylamides; Stereotyped Behavior; Time Factors

2005
Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat.
    Pharmacology, biochemistry, and behavior, 2005, Volume: 81, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Dyskinesia, Drug-Induced; Hydroxyindoleacetic Acid; Levodopa; Male; Norepinephrine; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Serotonin

2005